School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4072, Australia.
RDC Clinical, Newstead, Brisbane, QLD 4005, Australia.
Nutrients. 2022 Jan 18;14(3):427. doi: 10.3390/nu14030427.
This study aimed to assess the efficacy of a blood orange Citrus sinensis standardized extract from “Moro” cultivar, on weight loss in overweight but otherwise healthy individuals. Anthocyanins and particularly cyanidin 3-glucoside, found in a large variety of fruits including Sicilian blood oranges, can help to counteract weight gain and to reduce body fat accumulation through the modulation of antioxidant, anti-inflammatory and metabolic pathways. In this randomized, double blind, placebo-controlled study, all participants (overweight adults aged 20−65 years old) were randomized to receive either Moro blood orange standardized extract or a placebo daily for 6-months. The primary outcome measure was change in body mass and body composition at the end of the study. After 6-months, body mass (4.2% vs. 2.2%, p = 0.015), body mass index (p = 0.019), hip (3.4 cm vs. 2.0 cm, p = 0.049) and waist (3.9 cm vs. 1.7 cm, p = 0.017) circumferences, fat mass (p = 0.012) and fat distribution (visceral and subcutaneous fat p = 0.018 and 0.006, respectively) were all significantly better in the extract supplemented group compared to the placebo (p < 0.05). In addition, all safety markers of liver toxicity were within the normal range throughout the study for both analyzed groups. Concluding, the present study demonstrates that Moro blood orange standardized extract may be a safe and effective option for helping with weight loss when used in conjunction with diet and exercise.
本研究旨在评估来自“莫罗”品种的血橙(Citrus sinensis)标准化提取物对超重但健康的个体减肥的功效。在各种水果中发现的花青素,特别是在西西里血橙中发现的矢车菊素 3-葡萄糖苷,可以通过调节抗氧化、抗炎和代谢途径来帮助对抗体重增加和减少体脂肪积累。在这项随机、双盲、安慰剂对照研究中,所有参与者(年龄在 20-65 岁之间的超重成年人)均被随机分配每天接受莫罗血橙标准化提取物或安慰剂治疗,为期 6 个月。主要结局指标为研究结束时体重和身体成分的变化。6 个月后,体重(4.2%比 2.2%,p = 0.015)、体重指数(p = 0.019)、臀部(3.4 厘米比 2.0 厘米,p = 0.049)和腰围(3.9 厘米比 1.7 厘米,p = 0.017)、脂肪量(p = 0.012)和脂肪分布(内脏和皮下脂肪 p = 0.018 和 0.006,分别)在提取物补充组中均明显优于安慰剂组(p < 0.05)。此外,在整个研究过程中,两组的所有肝毒性安全标志物均在正常范围内。总之,本研究表明,莫罗血橙标准化提取物在与饮食和运动结合使用时,可能是一种安全有效的减肥选择。